Zephrex-D, Nexafed Make Marketing Pitch As Meth-Fighting Decongestants
This article was originally published in The Tan Sheet
Executive Summary
As their technology-enhanced pseudoephedrine decongestant products gain broader distribution, Westport Pharmaceuticals and Acura Pharmaceuticals are educating pharmacists about the drugs’ efficacy for congested consumers and as a means of curbing methamphetamine production.